Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients

  1. Castellano, D.
  2. Gonzláez-Larriba, J.L.
  3. Antón-Aparicio, L.M.
  4. Cassinello, J.
  5. Grande, E.
  6. Esteban, E.
  7. Sepúlveda, J.
Journal:
Expert Opinion on Pharmacotherapy

ISSN: 1465-6566 1744-7666

Year of publication: 2011

Volume: 12

Issue: 16

Pages: 2433-2439

Type: Article

DOI: 10.1517/14656566.2011.590132 GOOGLE SCHOLAR

Sustainable development goals